Beijing United Family Hospital and Alibaba DAMO Academy have launched a joint effort to bring advanced AI screening into clinical use.

Their flagship project uses a plain CT scan combined with DAMO Academy's multi-condition detection AI to facilitate early identification of gastrointestinal cancers and chronic diseases.

The technology has already internationally earned the FDA's 'Breakthrough Device' designation. Collaborators stress that combining AI with established international standards supports more accurate, patient-centred care.

The system streamlines diagnosis, reducing delays and improving reliability, especially for cancers that traditional screening often misses. Hospital leadership argues that the partnership shifts screening from reactive to proactive models.